| Status | Study |
| Recruiting |
Study Name: Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA) Condition: Arthritis, Psoriatic Date: 2016-01-13 Interventions: Drug: AIN457 (secukinumab) |
| Active, not recruiting |
Study Name: 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis Condition: Arthritis, Psoriatic Date: 2014-11-17 Interventions: Biological: Secukinumab Eligib |
| Recruiting |
Study Name: A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands Condition: Arthritis, Psoriatic Date: 2016-08-18 |
| Completed |
Study Name: A Study of Golimumab in Participants With Active Psoriatic Arthritis Condition: Arthritis, Psoriatic Date: 2014-07-02 Interventions: Drug: Placebo Participants wil |
| Completed |
Study Name: A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis Condition: Arthritis, Psoriatic Date: 2003-01-14 Interventions: Drug: Infliximab |
| Completed |
Study Name: Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis Condition: Arthritis, Psoriatic Date: 2009-07-10 Interventions: Other: Questionnaire This is a non-interventional study |
| Completed |
Study Name: A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis Condition: Arthritis, Psoriatic Date: 2005-12-12 Interventions: Biological: golimumab 50 mg sc |
| Completed |
Study Name: A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis Condition: Arthritis, Psoriatic Date: 2009-11-05 Interventions: Drug: Placebo SC injections |
| Recruiting |
Study Name: Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis Condition: Arthritis, Psoriatic Date: 2013-10-29 Interventions: Drug: Tofacitinib Tofacitinib |
| Recruiting |
Study Name: A Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in Belgium Condition: Arthritis, Psoriatic Date: 2017-03-24 Interventions: Drug: apremilast Psoriatic arthritis patients treated with Otezla® (apremilast) in Belgium |